GENENTECH INC.

In News

Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing - Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center - Apr 19, 2026

Ventus Therapeutics Enters into a Collaboration and License Agreement with Genentech to Discover and Develop Small-Molecule Medicines Using Ventus’ ReSOLVE® Platform - Ventus Therapeutics

Ventus Therapeutics - Oct 21, 2025

Biogen owes Genentech $88 million in MS drug dispute, US judge says - Reuters

Reuters - Oct 01, 2025

Genentech Announces Positive Phase II Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People Living With Obesity - Yahoo Finance

Yahoo Finance - Jan 26, 2026

Genentech licenses Sanegene’s RNAi asset in $1.7B deal - BioWorld News

BioWorld News - Feb 03, 2026

Biotech company Genentech is doubling its investment into Holly Springs - Axios

Axios - Jan 20, 2026

Biotech company Genentech breaks ground in Holly Springs - WRAL

WRAL - Aug 25, 2025

Andrew Chan Talks Transformative Medicines Nov. 17 - Research Horizons

Research Horizons - Oct 31, 2025

Biogen Told To Pay Genentech $88M After IP Royalties Mistrial - Law360

Law360 - Sep 30, 2025

Genentech inks US$400m IBD deal with OMass Therapeutics - European Biotechnology Magazine

European Biotechnology Magazine - Sep 02, 2025

Genentech’s Latest Layoffs Bring Total to Nearly 350 This Year - BioSpace

BioSpace - Oct 29, 2025

Roche’s Genentech more than doubles North Carolina facility investment to $2B - Manufacturing Dive

Manufacturing Dive - Jan 22, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment